Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer

E-ISSN： 1873-4286|22|20|2947-2959

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.20, 2016-06, pp. : 2947-2959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 868-876

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Target Hsp90 and Cancer Hallmarks

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Multiclass Comparative Virtual Screening to Identify Novel Hsp90 Inhibitors: A Therapeutic Breast Cancer Drug Target

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 57-64

Bentham Science Publishers

Access to resources Recommend Favorite

HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy

Current Medicinal Chemistry, Vol. 16, Iss. 24, 2009-08 ,pp. : 3081-3092

Bentham Science Publishers

Access to resources Recommend Favorite